Jasper Therapeutics, Inc.JSPRNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank60
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Latest
-20.23%
↑ 88% vs avg
Percentile
P60
Within normal range
Streak
1 yr
Consecutive declineDecelerating
Average
-163.67%
Historical baseline
PeriodValue
2024-20.23%
2023-13.54%
2022-36.17%
2021-84.37%
2020-827.73%
20190.00%